View Post

Lehi biotech company developing cancer treatment drug

In In The News by Barbara Jacoby0 Comments

By: Jason Lee From: deseretnews.com David Bearss doesn’t remember his grandfather. The family patriarch was in his 40s when he was diagnosed with colon cancer in 1969 — the year Bearss was born. He died before Bearss was old enough to know him. “I have pictures of him holding me as a baby,” Bearss said. “But with cancer in those …

View Post

Biopharmaceutical Company Granted Orphan Designation from the European Medicines Agency

In In The News by Barbara Jacoby0 Comments

Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Iomab-B – Orphan designation is expected to provide increased communication and guidance from regulators and 10-year market exclusivity should marketing authorization be obtained. – Orphan designation for Iomab-B follows SME (small or medium-sized enterprise) status, which was granted in August 2016. – Iomab-B now has orphan designation in the …

Wow. Agios’ Experimental Leukemia Drug Makes Cancer Undetectable In Three Patients

In In The News by Barbara Jacoby0 Comments

By: Matthew Harper From: Forbes.com Agios, a biotechnology company based in Cambridge, Mass., has seemed in some ways a sign of the overexcitement of the recent biotech boom. After all, the company, despite an experienced management team, a July public stock offering that raised more than $100 million, and great scientific ideas, hasn’t been able to show a single result …